HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Te Liu Selected Research

Diethylhexyl Phthalate (DEHP)

3/2022Corrigendum to "The interference of DEHP in precocious puberty of females mediated by the hypothalamic IGF-1/PI3K/Akt/mTOR signaling pathway" [Ecotoxicol. Environ. Saf. 181 (2019) 362-369].
1/2022Effect of Di-(2-ethylhexyl) phthalate on the hypothalamus-pituitary-thyroid axis in adolescent rat.
4/2020Role of the 17β-hydroxysteroid dehydrogenase signalling pathway in di-(2-ethylhexyl) phthalate-induced ovarian dysfunction: An in vivo study.
10/2019The interference of DEHP in precocious puberty of females mediated by the hypothalamic IGF-1/PI3K/Akt/mTOR signaling pathway.
8/2018Di-(2-ethylhexyl) phthalate induces precocious puberty in adolescent female rats.
2/2018Di-(2-ethylhexyl)-phthalate induces glucose metabolic disorder in adolescent rats.
1/2018Correction and Republication: Effect of Di-(2-ethylhexyl) phthalate on the hypothalamus-pituitary-thyroid axis in adolescent rat.
11/2016Effects of Di-(2-ethylhexyl) Phthalate on the Hypothalamus-Uterus in Pubertal Female Rats.
11/2016Effects of Di-(2-ethylhexyl) Phthalate on Lipid Metabolism by the JAK/STAT Pathway in Rats.
7/2014Effects of di-(2-ethylhexyl) phthalate on the hypothalamus-pituitary-ovarian axis in adult female rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Te Liu Research Topics

Disease

22Neoplasms (Cancer)
01/2022 - 12/2009
13Primary Ovarian Insufficiency
04/2022 - 01/2012
10Parkinson Disease (Parkinson's Disease)
06/2021 - 02/2012
9Atherosclerosis
01/2022 - 06/2013
8Ovarian Neoplasms (Ovarian Cancer)
12/2019 - 12/2009
6Body Weight (Weight, Body)
01/2022 - 07/2014
6Inflammation (Inflammations)
01/2021 - 10/2017
5Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2021
5Macular Degeneration (Age-Related Maculopathy)
01/2021 - 01/2017
4Alzheimer Disease (Alzheimer's Disease)
10/2019 - 12/2013
3Precocious Puberty
03/2022 - 08/2018
3Glioblastoma (Glioblastoma Multiforme)
10/2021 - 08/2016
3Carcinogenesis
10/2021 - 10/2017
3Endometrial Neoplasms (Endometrial Cancer)
01/2019 - 10/2011
3Prostatic Neoplasms (Prostate Cancer)
01/2018 - 07/2010
2Hemorrhoids
02/2021 - 07/2019
2Autoimmune Diseases (Autoimmune Disease)
01/2021 - 12/2018
2Glioma (Gliomas)
01/2020 - 08/2016
2Mitochondrial Diseases (Mitochondrial Disease)
01/2020 - 09/2014
2Carcinoma (Carcinomatosis)
01/2018 - 07/2010
2Acute Kidney Injury (Acute Renal Failure)
01/2017 - 08/2011
2Neoplasm Metastasis (Metastasis)
04/2016 - 05/2014
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2016 - 01/2015
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2022
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2021
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
05/2021
1Infertility (Sterility)
05/2021
1Cytokine Release Syndrome
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1Rheumatoid Arthritis
01/2021
1Arthritis (Polyarthritis)
01/2021
1Osteomyelitis
01/2021
1Atherosclerotic Plaque (Atheroma)
01/2021
1Joint Instability (Joint Laxity)
01/2021
1Critical Illness (Critically Ill)
01/2021
1Neuralgia (Stump Neuralgia)
01/2021
1Fibrosis (Cirrhosis)
01/2021
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2021
1Cold Injury
01/2021
1Pain (Aches)
01/2021
1COVID-19
01/2021
1Contracture
01/2021

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2011
13MicroRNAs (MicroRNA)IBA
01/2022 - 09/2011
10Diethylhexyl Phthalate (DEHP)IBA
03/2022 - 07/2014
6Messenger RNA (mRNA)IBA
04/2022 - 07/2014
6Amyloid (Amyloid Fibrils)IBA
01/2021 - 12/2013
6Pharmaceutical PreparationsIBA
01/2020 - 07/2010
6Long Noncoding RNAIBA
10/2017 - 09/2014
4LipidsIBA
12/2019 - 11/2016
3Biological ProductsIBA
01/2022 - 01/2015
3Sirtuin 1IBA
01/2021 - 08/2015
3oxidized low density lipoproteinIBA
01/2020 - 07/2018
3fisetinIBA
01/2020 - 01/2019
3CytokinesIBA
02/2018 - 10/2017
2Circular RNAIBA
01/2022 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2018
2p38 Mitogen-Activated Protein KinasesIBA
01/2022 - 01/2021
2Imatinib Mesylate (Gleevec)FDA Link
10/2021 - 01/2020
2SugarsIBA
08/2021 - 01/2021
2ThymopentinIBA
08/2021 - 01/2021
2DNA (Deoxyribonucleic Acid)IBA
06/2021 - 01/2020
2Hormones (Hormone)IBA
05/2021 - 01/2018
2EnzymesIBA
01/2021 - 08/2015
2polydopamineIBA
01/2021 - 01/2020
2Polysaccharides (Glycans)IBA
01/2020 - 01/2019
2Neuroprotective AgentsIBA
01/2020 - 08/2015
2AnisomycinIBA
12/2019 - 04/2016
2Insulin (Novolin)FDA Link
02/2018 - 11/2016
2LeptinIBA
02/2018 - 11/2016
2InterleukinsIBA
01/2018 - 01/2017
2CurcuminIBA
01/2018 - 10/2017
2Interleukin-6 (Interleukin 6)IBA
01/2018 - 01/2016
2Amyloid beta-PeptidesIBA
10/2017 - 01/2017
2Competitive Endogenous RNAIBA
10/2017 - 01/2016
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2017 - 09/2016
2Cisplatin (Platino)FDA LinkGeneric
01/2015 - 05/2014
1CateninsIBA
01/2022
1Environmental Pollutants (Pollutants, Environmental)IBA
01/2022
1TubulinIBA
10/2021
1PyrrolesIBA
10/2021
1Tyrosine Kinase InhibitorsIBA
10/2021
11-(2-chloroethyl)-1-nitrosourea (CNU)IBA
10/2021
1SteroidsIBA
05/2021
16-methyladenineIBA
02/2021
1Histones (Histone)IBA
01/2021
1Apolipoproteins E (ApoE)IBA
01/2021
1ApolipoproteinsIBA
01/2021
1ferric citrateIBA
01/2021
1Factor XI (Plasma Thromboplastin Antecedent)IBA
01/2021
1SARS-CoV-2 spike proteinIBA
01/2021
1CollagenIBA
01/2021
1Ammonium CompoundsIBA
01/2021

Therapy/Procedure

3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 01/2016
3Therapeutics
01/2021 - 01/2016
3Transplantation
06/2016 - 02/2012
3Drug Therapy (Chemotherapy)
04/2016 - 01/2012
1Electroacupuncture
04/2022
1Conservative Treatment
01/2021
1Analgesia
01/2021